Back to search
Hearing Loss, Mixed Conductive-Sensorineural
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Hearing Loss, Mixed Conductive-Sensorineural trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Hearing Loss, Mixed Conductive-Sensorineural trials you may qualify forChildren who are deaf or hard-of-hearing (D/HH) are at risk of speech and language delays, which can be mitigated through early identification and intervention.…
This study is performed to collect safety and performance data supporting the use of the Sentio system in children below 12 years of age. The system is currentl…
This study will look at how much sound amplification (gain) different bone-anchored hearing devices can provide. The goal is to understand if there are differen…
Following informed consent signature and upon verification of eligibility and execution of informed consent, subjects will be assigned a study code. The study c…
The primary objective of the study is to evaluate OID hearing intervention on cognition among patients who could vs. do utilize an OID. We will also evaluate th…
The Bonebridge (BB) is a partially implantable active transcutaneous bone conduction hearing system manufactured by MED-EL Elektromedizinische Geräte Gesellscha…
This study, titled "The BONEBRIDGE in Children Under Five: Premarket Clinical Investigation" (Study ID 2023BB006), looks at kids under five who have received th…
The goal of this interventional study is to confirm the safety and performance of the latest generation Osia System and to examine its benefits compared to the…